SCHEMBL9391898

SCHEMBL9391898

Cc1ccc2c(c1)Sc1cc(Br)ccc1N2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 4/20 0.55
MAPT P10636 8/20 0.50
NOX1 Q9Y5S8 7/20 0.50
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
GAA P10253 6/20 0.50
TDP1 Q9NUW8 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
EPHX2 P34913 1/20 0.46
MAPK1 P28482 4/20 0.45
ALOX15 P16050 3/20 0.45
HSD17B10 Q99714 2/20 0.45
ALOX12 P18054 2/20 0.43
ALDH1A1 P00352 4/20 0.41
POLB P06746 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29637682 0.88 SNCA (0.66) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL2582828 0.88 SNCA (0.66) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL29640485 0.88 MAPT (0.59) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL225916 0.88 MAPT (0.59) SNCAMAPTNOX1MEN1KMT2A
Bromide SCHEMBL30448580 0.86 SNCA (0.64) SNCAMAPTNOX1MEN1KMT2A
Bromide SCHEMBL20495634 0.86 SNCA (0.64) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL30065446 0.81 SNCA (0.58) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL205578 0.81 SNCA (0.58) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL2756476 0.81 NOX1 (0.53) SNCAMAPTNOX1MEN1KMT2A
SCHEMBL239549 0.79 NOX1 (0.65) SNCAMAPTNOX1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994017095-A1 ANALOGS OF RECEPTOR TYROSINE ACTIVATION MOTIFS AND THERAPEUTIC USES THEREOF ARIAD PHARMACEUTICALS, INC. (US) 1994-08-04 WO disclosed